Preemptively managing the side effects of cancer treatment through model-driven clinical decision support: A case study.

Presented By

Michael Carey Scalzo, MPH
Director, Dana-Farber Pathways

Description

Cancer treatment has side effects. Regardless of their diagnosis, all cancer patients have the potential to experience a wide range of symptoms related to therapy or the progression of their disease. Given that the current approach to symptom management is often fragmented and reactive, Dana-Farber Cancer Institute has launched an innovative initiative to preemptively managed the side effects of cancer therapy by leveraging digital technologies. Central to this effort is Dana-Farber’s partnership with Trisotech to integrate clinical decision support automation into providers’ existing Epic EHR workflows.

View the slides